World's Best Scientists 2026 revealed!
Michael A. Pfaller

Michael A. Pfaller

Award Badge
Microbiology
USA
2026

D-Index & Metrics

Best Scientists

D-Index
166
Citations
108500
World Ranking
1005
National Ranking
594

Microbiology

D-Index
169
Citations
109983
World Ranking
12
National Ranking
6

Medicine

D-Index
170
Citations
110861
World Ranking
523
National Ranking
309

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award
  • 1997 - ASM Award for Research in Clinical Microbiology, American Society for Microbiology

Overview

Michael A. Pfaller is affiliated with JMI Laboratories in the United States and has a research focus within the field of Medicine, particularly in Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology, Clinical Biochemistry, and Pharmacology.

The main topics covered in their work include:

  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Antibiotic Use and Resistance
  • Bacterial Identification and Susceptibility Testing
  • Antibiotic Resistance in Bacteria
  • Antimicrobial Resistance in Staphylococcus
  • Nail Diseases and Treatments

Some of the recent papers authored by Michael A. Pfaller are:

  • Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018), 2020, Antimicrobial Agents and Chemotherapy
  • Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018, 2020, Antimicrobial Agents and Chemotherapy
  • Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018-2019), 2021, Journal of Global Antimicrobial Resistance

Frequent co-authors collaborating with Michael A. Pfaller include:

  • Mariana Castanheira
  • Cecília G Carvalhaes
  • Paul R. Rhomberg
  • Michael D. Huband
  • Robert K. Flamm

Regular publication venues for Michael A. Pfaller's work include:

  • Open Forum Infectious Diseases
  • Antimicrobial Agents and Chemotherapy
  • Diagnostic Microbiology and Infectious Disease
  • Journal of Global Antimicrobial Resistance
  • Future Microbiology

Michael A. Pfaller has contributed to book publications as well, including works published by ASM Press eBooks and Frontiers Media. Notable titles include Manual of Clinical Microbiology (2020) and Developments in Implicit Measurements (2022).

Among the recognitions, Michael A. Pfaller received the ASM Award for Research in Clinical Microbiology from the American Society for Microbiology in 1997.

Best Publications

  • Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

    M. A. Pfaller;D. J. Diekema

  • Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis

    Michael B. Edmond;Sarah E. Wallace;Donna K. McClish;Michael A. Pfaller

  • Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999

    D. J. Diekema;M. A. Pfaller;F. J. Schmitz;J. Smayevsky

  • Attributable Mortality of Nosocomial Candidemia, Revisited

    Olafur Gudlaugsson;Olafur Gudlaugsson;Shane Gillespie;Kathleen Lee;Jeff Vande Berg

  • Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

    John H. Rex;Michael A. Pfaller;John N. Galgiani;Marilyn S. Bartlett

  • Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay

    Sergio B. Wey;Motomi Mori;Michael A. Pfaller;Robert F. Woolson

  • Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

    David L. Horn;Dionissios Neofytos;Dionissios Neofytos;Elias J. Anaissie;Jay A. Fishman

  • Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment.

    Michael A. Pfaller

  • RESISTANCE OF CANDIDA SPECIES TO FLUCONAZOLE

    J H Rex;M G Rinaldi;M A Pfaller

  • Epidemiology of Invasive Mycoses in North America

    Michael A Pfaller;Daniel J Diekema

  • A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis

    R L Greenman;R M Schein;M A Martin;R P Wenzel

  • Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

    Barbara D. Alexander;Melissa D. Johnson;Christopher D. Pfeiffer;Cristina Jiménez-Ortigosa

  • Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.

    Trish M. Perl;Joseph J. Cullen;Richard P. Wenzel;M. Bridget Zimmerman

  • Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

    M. A. Pfaller;D. J. Diekema;D. L. Gibbs;V. A. Newell

  • Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus

    M. A. Pfaller;D. J. Diekema

  • Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study

    Henry M. Blumberg;Henry M. Blumberg;William R. Jarvis;J. Michael Soucie;Jack E. Edwards

  • Risk Factors for Hospital-Acquired Candidemia: A Matched Case-Control Study

    Sergio B. Wey;Motomi Mori;Michael A. Pfaller;Robert F. Woolson

  • Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

    Michael A. Pfaller;Ronald N. Jones;Gary V. Doern;Kari Kugler

  • International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.

    M. A. Pfaller;D. J. Diekema;R. N. Jones;H. S. Sader

  • Risk factors for candidemia in neonatal intensive care unit patients

    L Saiman;E Ludington;M Pfaller;S Rangel-Frausto

  • Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016.

    Michael A Pfaller;Daniel J Diekema;John D Turnidge;Mariana Castanheira

Frequent Co-Authors

Ronald N. Jones
Ronald N. Jones JMI Laboratories
Daniel J. Diekema
Daniel J. Diekema University of Iowa Hospitals and Clinics
Shawn A. Messer
Shawn A. Messer Oregon Health & Science University
Mariana Castanheira
Mariana Castanheira JMI Laboratories
Richard J. Hollis
Richard J. Hollis University of Iowa
Richard P. Wenzel
Richard P. Wenzel Virginia Commonwealth University
Robert K. Flamm
Robert K. Flamm JMI Laboratories
Helio S. Sader
Helio S. Sader JMI Laboratories
Rodrigo E. Mendes
Rodrigo E. Mendes JMI Laboratories
Paul R. Rhomberg
Paul R. Rhomberg University of Iowa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open up diverse career opportunities. Fields like healthcare and public health offer flexible online programs that complement microbiology expertise. For instance, if you want to enter healthcare administration or support roles, look into the shortest online medical billing and coding certificate programs. These programs provide a quick pathway into vital healthcare operations.

Additionally, aspiring professionals can consider a variety of online healthcare degrees. These degrees often provide the flexibility needed to balance studies with other commitments while gaining knowledge that complements microbiology careers, such as clinical roles or research support.

Public health is another growing area related to microbiology. Many universities offer online public health masters programs easy to get into, making it accessible for students looking to expand their impact in community health, epidemiology, or disease prevention.

For those interested in working with children and families affected by illness, becoming a child life specialist is a rewarding option. Understanding career prospects and earning potential is crucial, and resources like how much does a child life specialist make can help guide your decisions.

Best Scientists Citing Michael A. Pfaller

Trending Scientists